Bio-Thera And Macter Partner On Bevacizumab

Marketing Deal Covers BAT1706 Biosimilar To Avastin In Pakistan And Afghanistan

 
• By Dave Wallace

Bio-Thera Solutions has struck a deal with Macter International for rights to its BAT1706 biosimilar rival to Avastin (bevacizumab) in Pakistan and Afghanistan.

Pakistan and Afghanistan under magnifying glass on map
The deal covers bevacizumab in Pakistan and Afghanistan • Source: Shutterstock

More from Deals

More from Business